Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARegT1D: Characterization of T Cells in Recent Onset Type 1 Diabetes
NCT06427421Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2025
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Frequency and phenotype of Tregs at 4 weeks. Started May 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06427421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06427421.